157 related articles for article (PubMed ID: 10337002)
1. Role of estradiol metabolism and CYP1A1 polymorphisms in breast cancer risk.
Taioli E; Bradlow HL; Garbers SV; Sepkovic DW; Osborne MP; Trachman J; Ganguly S; Garte SJ
Cancer Detect Prev; 1999; 23(3):232-7. PubMed ID: 10337002
[TBL] [Abstract][Full Text] [Related]
2. A common CYP1B1 polymorphism is associated with 2-OHE1/16-OHE1 urinary estrone ratio.
Paracchini V; Pedotti P; Raimondi S; Garte S; Bradlow HL; Sepkovic DW; Taioli E
Clin Chem Lab Med; 2005; 43(7):702-6. PubMed ID: 16207128
[TBL] [Abstract][Full Text] [Related]
3. CYP1A1 and CYP1B1 polymorphisms and their association with estradiol and estrogen metabolites in women who are premenopausal and perimenopausal.
Sowers MR; Wilson AL; Kardia SR; Chu J; McConnell DS
Am J Med; 2006 Sep; 119(9 Suppl 1):S44-51. PubMed ID: 16949388
[TBL] [Abstract][Full Text] [Related]
4. Polychlorinated biphenyls, cytochrome P450 1A1 (CYP1A1) polymorphisms, and breast cancer risk among African American women and white women in North Carolina: a population-based case-control study.
Li Y; Millikan RC; Bell DA; Cui L; Tse CK; Newman B; Conway K
Breast Cancer Res; 2005; 7(1):R12-8. PubMed ID: 15642161
[TBL] [Abstract][Full Text] [Related]
5. Urinary 2/16 alpha-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk.
Ho GH; Luo XW; Ji CY; Foo SC; Ng EH
Ann Acad Med Singap; 1998 Mar; 27(2):294-9. PubMed ID: 9663330
[TBL] [Abstract][Full Text] [Related]
6. A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women.
Taioli E; Trachman J; Chen X; Toniolo P; Garte SJ
Cancer Res; 1995 Sep; 55(17):3757-8. PubMed ID: 7641189
[TBL] [Abstract][Full Text] [Related]
7. Effects of pesticides on the ratio of 16 alpha/2-hydroxyestrone: a biologic marker of breast cancer risk.
Bradlow HL; Davis DL; Lin G; Sepkovic D; Tiwari R
Environ Health Perspect; 1995 Oct; 103 Suppl 7(Suppl 7):147-50. PubMed ID: 8593862
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan.
Huang CS; Shen CY; Chang KJ; Hsu SM; Chern HD
Br J Cancer; 1999 Aug; 80(11):1838-43. PubMed ID: 10468307
[TBL] [Abstract][Full Text] [Related]
9. Cigarette smoking, cytochrome P4501A1 polymorphisms, and breast cancer among African-American and white women.
Li Y; Millikan RC; Bell DA; Cui L; Tse CK; Newman B; Conway K
Breast Cancer Res; 2004; 6(4):R460-73. PubMed ID: 15217514
[TBL] [Abstract][Full Text] [Related]
10. The ratio of the estradiol metabolites 2-hydroxyestrone (2-OHE1) and 16α-hydroxyestrone (16-OHE1) may predict breast cancer risk in postmenopausal but not in premenopausal women: two case-control studies.
Ruan X; Seeger H; Wallwiener D; Huober J; Mueck AO
Arch Gynecol Obstet; 2015 May; 291(5):1141-6. PubMed ID: 25318606
[TBL] [Abstract][Full Text] [Related]
11. Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and family history of breast cancer in premenopausal women.
Ursin G; London S; Yang D; Tseng CC; Pike MC; Bernstein L; Stanczyk FZ; Gentzschein E
Breast Cancer Res Treat; 2002 Mar; 72(2):139-43. PubMed ID: 12038704
[TBL] [Abstract][Full Text] [Related]
12. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
13. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer.
Bailey LR; Roodi N; Dupont WD; Parl FF
Cancer Res; 1998 Nov; 58(22):5038-41. PubMed ID: 9823305
[TBL] [Abstract][Full Text] [Related]
14. A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer.
Ursin G; London S; Stanczyk FZ; Gentzschein E; Paganini-Hill A; Ross RK; Pike MC
Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):601-5. PubMed ID: 9168002
[TBL] [Abstract][Full Text] [Related]
15. Potential differences in breast cancer risk factors based on CYP1A1 MspI and African-American-specific genotypes.
Zhu K; Hunter S; Payne-Wilks K; Sutcliffe C; Bentley C; Roland CL; Williams SM
Ethn Dis; 2006; 16(1):207-15. PubMed ID: 16599372
[TBL] [Abstract][Full Text] [Related]
16. Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women.
Ursin G; London S; Stanczyk FZ; Gentzschein E; Paganini-Hill A; Ross RK; Pike MC
J Natl Cancer Inst; 1999 Jun; 91(12):1067-72. PubMed ID: 10379970
[TBL] [Abstract][Full Text] [Related]
17. Lung cancer risk and CYP1A1 genotype in African Americans.
Taioli E; Ford J; Trachman J; Li Y; Demopoulos R; Garte S
Carcinogenesis; 1998 May; 19(5):813-7. PubMed ID: 9635868
[TBL] [Abstract][Full Text] [Related]
18. Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis.
Sergentanis TN; Economopoulos KP
Breast Cancer Res Treat; 2010 Jul; 122(2):459-69. PubMed ID: 20035380
[TBL] [Abstract][Full Text] [Related]
19. Estrogen metabolites and the risk of breast cancer in older women.
Cauley JA; Zmuda JM; Danielson ME; Ljung BM; Bauer DC; Cummings SR; Kuller LH
Epidemiology; 2003 Nov; 14(6):740-4. PubMed ID: 14569192
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans.
Bailey LR; Roodi N; Verrier CS; Yee CJ; Dupont WD; Parl FF
Cancer Res; 1998 Jan; 58(1):65-70. PubMed ID: 9426059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
